Medical Care

Global Immuno-Oncology Market Research Report 2025

The global market for Immuno-Oncology was valued at US$ 57510 million in the year 2024 and is projected to reach a revised size of US$ 150070 million by 2031, growing at a CAGR of 14.9% during the forecast period.
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body"s own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
The industry"s leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.
This report aims to provide a comprehensive presentation of the global market for Immuno-Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-Oncology.
The Immuno-Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immuno-Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immuno-Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
Segment by Type
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immuno-Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Cytokine-Based Immunotherapy
1.2.4 Cancer Vaccines
1.2.5 CAR-T Cell Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Immuno-Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Oncology Market Perspective (2020-2031)
2.2 Global Immuno-Oncology Growth Trends by Region
2.2.1 Global Immuno-Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Immuno-Oncology Historic Market Size by Region (2020-2025)
2.2.3 Immuno-Oncology Forecasted Market Size by Region (2026-2031)
2.3 Immuno-Oncology Market Dynamics
2.3.1 Immuno-Oncology Industry Trends
2.3.2 Immuno-Oncology Market Drivers
2.3.3 Immuno-Oncology Market Challenges
2.3.4 Immuno-Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Oncology Players by Revenue
3.1.1 Global Top Immuno-Oncology Players by Revenue (2020-2025)
3.1.2 Global Immuno-Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Immuno-Oncology Revenue
3.4 Global Immuno-Oncology Market Concentration Ratio
3.4.1 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Revenue in 2024
3.5 Global Key Players of Immuno-Oncology Head office and Area Served
3.6 Global Key Players of Immuno-Oncology, Product and Application
3.7 Global Key Players of Immuno-Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Oncology Breakdown Data by Type
4.1 Global Immuno-Oncology Historic Market Size by Type (2020-2025)
4.2 Global Immuno-Oncology Forecasted Market Size by Type (2026-2031)
5 Immuno-Oncology Breakdown Data by Application
5.1 Global Immuno-Oncology Historic Market Size by Application (2020-2025)
5.2 Global Immuno-Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Immuno-Oncology Market Size (2020-2031)
6.2 North America Immuno-Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Immuno-Oncology Market Size by Country (2020-2025)
6.4 North America Immuno-Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immuno-Oncology Market Size (2020-2031)
7.2 Europe Immuno-Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Immuno-Oncology Market Size by Country (2020-2025)
7.4 Europe Immuno-Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Oncology Market Size (2020-2031)
8.2 Asia-Pacific Immuno-Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Immuno-Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Immuno-Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immuno-Oncology Market Size (2020-2031)
9.2 Latin America Immuno-Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Immuno-Oncology Market Size by Country (2020-2025)
9.4 Latin America Immuno-Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Oncology Market Size (2020-2031)
10.2 Middle East & Africa Immuno-Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Immuno-Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Immuno-Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Immuno-Oncology Introduction
11.1.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2020-2025)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Details
11.2.2 Merck & Co., Inc. Business Overview
11.2.3 Merck & Co., Inc. Immuno-Oncology Introduction
11.2.4 Merck & Co., Inc. Revenue in Immuno-Oncology Business (2020-2025)
11.2.5 Merck & Co., Inc. Recent Development
11.3 Roche AG
11.3.1 Roche AG Company Details
11.3.2 Roche AG Business Overview
11.3.3 Roche AG Immuno-Oncology Introduction
11.3.4 Roche AG Revenue in Immuno-Oncology Business (2020-2025)
11.3.5 Roche AG Recent Development
11.4 AstraZeneca, Plc
11.4.1 AstraZeneca, Plc Company Details
11.4.2 AstraZeneca, Plc Business Overview
11.4.3 AstraZeneca, Plc Immuno-Oncology Introduction
11.4.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2020-2025)
11.4.5 AstraZeneca, Plc Recent Development
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Details
11.5.2 Sanofi S.A. Business Overview
11.5.3 Sanofi S.A. Immuno-Oncology Introduction
11.5.4 Sanofi S.A. Revenue in Immuno-Oncology Business (2020-2025)
11.5.5 Sanofi S.A. Recent Development
11.6 Dendreon Pharmaceuticals
11.6.1 Dendreon Pharmaceuticals Company Details
11.6.2 Dendreon Pharmaceuticals Business Overview
11.6.3 Dendreon Pharmaceuticals Immuno-Oncology Introduction
11.6.4 Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2020-2025)
11.6.5 Dendreon Pharmaceuticals Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Immuno-Oncology Introduction
11.7.4 Novartis Revenue in Immuno-Oncology Business (2020-2025)
11.7.5 Novartis Recent Development
11.8 Gilead Sciences Inc.
11.8.1 Gilead Sciences Inc. Company Details
11.8.2 Gilead Sciences Inc. Business Overview
11.8.3 Gilead Sciences Inc. Immuno-Oncology Introduction
11.8.4 Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2020-2025)
11.8.5 Gilead Sciences Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Immuno-Oncology Introduction
11.9.4 Merck KGaA Revenue in Immuno-Oncology Business (2020-2025)
11.9.5 Merck KGaA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Immuno-Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immune Checkpoint Inhibitors
Table 3. Key Players of Cytokine-Based Immunotherapy
Table 4. Key Players of Cancer Vaccines
Table 5. Key Players of CAR-T Cell Therapy
Table 6. Key Players of Others
Table 7. Global Immuno-Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Immuno-Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Immuno-Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Immuno-Oncology Market Share by Region (2020-2025)
Table 11. Global Immuno-Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Immuno-Oncology Market Share by Region (2026-2031)
Table 13. Immuno-Oncology Market Trends
Table 14. Immuno-Oncology Market Drivers
Table 15. Immuno-Oncology Market Challenges
Table 16. Immuno-Oncology Market Restraints
Table 17. Global Immuno-Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Immuno-Oncology Market Share by Players (2020-2025)
Table 19. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2024)
Table 20. Ranking of Global Top Immuno-Oncology Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Immuno-Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Immuno-Oncology, Headquarters and Area Served
Table 23. Global Key Players of Immuno-Oncology, Product and Application
Table 24. Global Key Players of Immuno-Oncology, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Immuno-Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Immuno-Oncology Revenue Market Share by Type (2020-2025)
Table 28. Global Immuno-Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Immuno-Oncology Revenue Market Share by Type (2026-2031)
Table 30. Global Immuno-Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Immuno-Oncology Revenue Market Share by Application (2020-2025)
Table 32. Global Immuno-Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Immuno-Oncology Revenue Market Share by Application (2026-2031)
Table 34. North America Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Immuno-Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Immuno-Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Immuno-Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Immuno-Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Immuno-Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Immuno-Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Immuno-Oncology Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Immuno-Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Immuno-Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Immuno-Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Immuno-Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 49. Bristol-Myers Squibb Company Details
Table 50. Bristol-Myers Squibb Business Overview
Table 51. Bristol-Myers Squibb Immuno-Oncology Product
Table 52. Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 53. Bristol-Myers Squibb Recent Development
Table 54. Merck & Co., Inc. Company Details
Table 55. Merck & Co., Inc. Business Overview
Table 56. Merck & Co., Inc. Immuno-Oncology Product
Table 57. Merck & Co., Inc. Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 58. Merck & Co., Inc. Recent Development
Table 59. Roche AG Company Details
Table 60. Roche AG Business Overview
Table 61. Roche AG Immuno-Oncology Product
Table 62. Roche AG Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 63. Roche AG Recent Development
Table 64. AstraZeneca, Plc Company Details
Table 65. AstraZeneca, Plc Business Overview
Table 66. AstraZeneca, Plc Immuno-Oncology Product
Table 67. AstraZeneca, Plc Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 68. AstraZeneca, Plc Recent Development
Table 69. Sanofi S.A. Company Details
Table 70. Sanofi S.A. Business Overview
Table 71. Sanofi S.A. Immuno-Oncology Product
Table 72. Sanofi S.A. Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 73. Sanofi S.A. Recent Development
Table 74. Dendreon Pharmaceuticals Company Details
Table 75. Dendreon Pharmaceuticals Business Overview
Table 76. Dendreon Pharmaceuticals Immuno-Oncology Product
Table 77. Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 78. Dendreon Pharmaceuticals Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Immuno-Oncology Product
Table 82. Novartis Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Gilead Sciences Inc. Company Details
Table 85. Gilead Sciences Inc. Business Overview
Table 86. Gilead Sciences Inc. Immuno-Oncology Product
Table 87. Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 88. Gilead Sciences Inc. Recent Development
Table 89. Merck KGaA Company Details
Table 90. Merck KGaA Business Overview
Table 91. Merck KGaA Immuno-Oncology Product
Table 92. Merck KGaA Revenue in Immuno-Oncology Business (2020-2025) & (US$ Million)
Table 93. Merck KGaA Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report


List of Figures
Figure 1. Immuno-Oncology Picture
Figure 2. Global Immuno-Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Immuno-Oncology Market Share by Type: 2024 VS 2031
Figure 4. Immune Checkpoint Inhibitors Features
Figure 5. Cytokine-Based Immunotherapy Features
Figure 6. Cancer Vaccines Features
Figure 7. CAR-T Cell Therapy Features
Figure 8. Others Features
Figure 9. Global Immuno-Oncology Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Immuno-Oncology Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Case Studies
Figure 12. Drugstores Case Studies
Figure 13. Others Case Studies
Figure 14. Immuno-Oncology Report Years Considered
Figure 15. Global Immuno-Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Immuno-Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Immuno-Oncology Market Share by Region: 2024 VS 2031
Figure 18. Global Immuno-Oncology Market Share by Players in 2024
Figure 19. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Immuno-Oncology Revenue in 2024
Figure 21. North America Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Immuno-Oncology Market Share by Country (2020-2031)
Figure 23. United States Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Immuno-Oncology Market Share by Country (2020-2031)
Figure 27. Germany Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Immuno-Oncology Market Share by Region (2020-2031)
Figure 35. China Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Immuno-Oncology Market Share by Country (2020-2031)
Figure 43. Mexico Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Immuno-Oncology Market Share by Country (2020-2031)
Figure 47. Turkey Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Immuno-Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 51. Merck & Co., Inc. Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 52. Roche AG Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 53. AstraZeneca, Plc Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 54. Sanofi S.A. Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 55. Dendreon Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 57. Gilead Sciences Inc. Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 58. Merck KGaA Revenue Growth Rate in Immuno-Oncology Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies